Status:

UNKNOWN

Periodontal Disease and Cardiovascular Disease

Lead Sponsor:

Colgate Palmolive

Conditions:

Periodontal Diseases

Eligibility:

All Genders

18-75 years

Phase:

PHASE3

Brief Summary

To access the influence of triclosan dentifrice on the progression of periodontal disease in patients with coronary heart disease.

Eligibility Criteria

Inclusion

  • A minimum of 12 uncrowned teeth other than 3rd molars
  • Age 18 to 75 years
  • Informed consent

Exclusion

  • Prosthetic heart valves
  • Prosthetic joint replacement
  • Previous infective endocarditis
  • Requirement for antibiotic cover for dental treatment
  • Current treatment with warfarin

Key Trial Info

Start Date :

November 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2009

Estimated Enrollment :

438 Patients enrolled

Trial Details

Trial ID

NCT00763165

Start Date

November 1 2000

End Date

December 1 2009

Last Update

October 2 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Discipline of Medicine

Chermside, Australia